This document provides information about the anti-convulsant medication phenytoin (Dilantin). It lists the generic and trade names, classification, typical doses, administration route and schedule. It describes the peak time, onset, duration and normal dosage range. Nursing implications are outlined including contraindications, common side effects, interactions, and lab alterations. Instructions are provided for patients regarding monitoring, adherence, missed doses, withdrawal, dental hygiene and urine discoloration. The assessment section describes when the medication would be held or not given, and what would be evaluated after administration.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
The Best Practice Is The Lowest Effective Dose Your Third Psychiatric Consultation: Diet, Exercise, and Sleep Trump Medications Medication is the Last Option Your Fourth Psychiatric Consultation
Stability Indicating RP-HPLC Method For The Determination of Terbutaline Sulphate, Guaifenesin, Ambroxol Hydrochloride and Preservatives Content in Liquid Formulations
This document provides information about the anti-convulsant medication phenytoin (Dilantin). It lists the generic and trade names, classification, typical doses, administration route and schedule. It describes the peak time, onset, duration and normal dosage range. Nursing implications are outlined including contraindications, common side effects, interactions, and lab alterations. Instructions are provided for patients regarding monitoring, adherence, missed doses, withdrawal, dental hygiene and urine discoloration. The assessment section describes when the medication would be held or not given, and what would be evaluated after administration.
This document provides information about the anti-convulsant medication phenytoin (Dilantin). It lists the generic and trade names, classification, typical doses, administration route and schedule. It describes the peak time, onset, duration and normal dosage range. Nursing implications are outlined including contraindications, common side effects, interactions, and lab alterations. Instructions are provided for patients regarding monitoring, adherence, missed doses, withdrawal, dental hygiene and urine discoloration. The assessment section describes when the medication would be held or not given, and what would be evaluated after administration.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document provides information about the anti-convulsant medication phenytoin (Dilantin). It lists the generic and trade names, classification, typical doses, administration route and schedule. It describes the peak time, onset, duration and normal dosage range. Nursing implications are outlined including contraindications, common side effects, interactions, and lab alterations. Instructions are provided for patients regarding monitoring, adherence, missed doses, withdrawal, dental hygiene and urine discoloration. The assessment section describes when the medication would be held or not given, and what would be evaluated after administration.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Generic Name Trade Name Classification Dose Route Time/frequency
Phenytoin Dilantin Antiarrhythmics, 300mg Q am and 400 PO Refer to dose anticonvulsants mg QHS Peak Onset Duration Normal dosage range 1.5-3 hours 2-24 hours 6-12 hours 200-600 mg/day in divided doses Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions Prevention of seizures N/A Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Limits seizure propagation by altering ion transport. May also .Contraindicated in pt’s with hypersensitivity, sinus bradycardia, decrease synaptic transmission. Indicated for prevention of sinoatrial block, 2nd- or 3rd-degree heart block, or Adams--Stokes seizures syndrome. Use cautiously in obese patients (initial dose of IV phenytoin should be based on ideal body weight + 1.33 times excess weight). Common side effects Ataxia, diplopia, nystagmus, hypotension, gingival hyperplasia, nausea, hypertrichosis, rashes Interactions with other patient drugs, OTC or herbal medicines Lab value alterations caused by medicine (ask patient specifically) CBC and platelet count, serum calcium, albumin, urinalysis, and hepatic May alter the effect of corticosteroids. and thyroid function tests should be monitored prior to and monthly for the first several months, then periodically throughout therapy. May cause increased serum alkaline phosphatase, GTT, and glucose levels. Serum folate concentrations should be monitored periodically during prolonged therapy. Toxicity and Overdose: Phenytoin: Serum phenytoin levels should be routinely monitored. Therapeutic blood levels are 10-20 mcg/ml in patients with normal serum albumin and renal function. Be sure to teach the patient the following about this medication May cause drowsiness or dizziness. Advise patient to carry identification at all times describing disease process and medication regimen. Advise patient to notify health care professional if skin rash, severe nausea or vomiting, drowsiness, slurred speech, unsteady gait, swollen glands, bleeding or tender gums, yellow skin or eyes, joint pain, fever, sore throat, unusual bleeding or bruising, or persistent headache occurs. Emphasize the importance of routine exams to monitor progress. Instruct patient to take medication exactly as directed, at the same time each day. If a dose is missed from a once-a-day schedule, take as soon as possible and return to regular dosing schedule. If taking several doses a day, take missed dose as soon as possible within 4 hr of next scheduled dose; do not double doses. Consult health care professional if doses are missed for 2 consecutive days. Abrupt withdrawal may lead to status epilepticus. Instruct patient on importance of good dental hygiene and seeing dentist frequently. Inform patient that phenytoin may color urine pink, red, or reddish brown, but color change is not significant. Advise patient not to take phenytoin within 2-3 hr of antacids or antidiarrheals
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this med? Check after giving Assess location, duration, frequency, and If the patient was experiencing signs of toxicity which are Decrease of seizures characteristics of seizure activity. EEG may be nystagmus, ataxia, confusion, nausea, slurred speech, and without excessive monitored Serum phenytoin levels should be dizziness or if serum levels were elevated above normal. sedation and no signs routinely monitored.periodically throughout of toxicity. therapy.
The Best Practice Is The Lowest Effective Dose Your Third Psychiatric Consultation: Diet, Exercise, and Sleep Trump Medications Medication is the Last Option Your Fourth Psychiatric Consultation
Stability Indicating RP-HPLC Method For The Determination of Terbutaline Sulphate, Guaifenesin, Ambroxol Hydrochloride and Preservatives Content in Liquid Formulations